Wellell Inc. (TPE:4106)
24.10
-0.25 (-1.03%)
Nov 20, 2026, 1:30 PM CST
Wellell Revenue
Wellell had revenue of 678.69M TWD in the quarter ending September 30, 2026, with 9.63% growth. This brings the company's total for the last twelve months to 2.56B, up 6.97% year-over-year. In the year 2025, Wellell had annual revenue of 2.40B with 0.74% growth. That makes Wellell the 24,707th largest company in the world by revenue and 1,084th in Taiwan.
Revenue (ttm)
2.56B
Revenue Growth
+6.97%
P/S Ratio
0.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.43B
Revenue by Geography
- Europe 2.11B 66.9%
- Asia 865.83M 27.5%
- America 176.36M 5.6%
Fiscal year ended Dec 31, 2025 See the full Wellell breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.40B | 17.68M | 0.74% |
| Dec 31, 2024 | 2.39B | -260.47M | -9.84% |
| Dec 31, 2023 | 2.65B | -16.60M | -0.62% |
| Dec 31, 2022 | 2.66B | 289.67M | 12.20% |
| Dec 31, 2021 | 2.37B | 370.03M | 18.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Apex Biotechnology | 1.86B |
| OK Biotech | 1.72B |
| Dynamic Medical Technologies | 1.42B |
| WeLeader Biomedical | 1.27B |
| AViTA | 1.05B |
| A Plus Biotechnology | 919.38M |
| Medimaging Integrated Solution | 744.42M |
| Applied BioCode | 666.54M |